vimarsana.com

Latest Breaking News On - Shanghai fosun pharmaceutical - Page 14 : vimarsana.com

Fosun Pharma Announces 2022 Annual Results: Achieved Steady Growth with Revenue from Record High Innovative Products and Global Commercialization Capability Improvement

Performance Highlights: During the reporting period, the revenue was RMB 43.952 billion, with a year-on-year growth of 12.66%; the net profit after deducting extraordinary gain or loss attributable. | March 28, 2023

vimarsana © 2020. All Rights Reserved.